Nagarsheth et al. found that KDM6B-mediated demethylation of H3K27me3 with the PRC2 component silenced Th1-type chemokines and suppressed effector T cell-mediated immunity, controlling immunosuppression in colon cancer [167]. Here, KDM6B is linked to malignant colon neoplasm.